The Serum Institute's endorsement of Anteotech's technology has...

  1. 2,823 Posts.
    lightbulb Created with Sketch. 1156
    The Serum Institute's endorsement of Anteotech's technology has essentially provided the company with the validation it needed among other biotech firms. As the leading biotech company specializing in life-saving biologicals, this move will serve as a wake-up call to similar companies and competitors worldwide.

    I've previously invested in a few ambitious companies that attempted to break into the Indian market but failed. This is the first time I've actually seen an Indian company invest in something outside their own country -Everyone says the same thing once you are in the circle of trust you are in...

    With the new MOU, I expect we'll see more companies taking notice, especially given that a world-leading vaccine manufacturer has done its due diligence and confirmed that Anteo is onto something significant.

    This is a business that will build on its successes.

    Anteo X is still in its preliminary stage, waiting for validation, which we will hopefully achieve with EV1 or EV2. I can see the merit in David's strategy of seeking validation from major players rather than smaller ones. Once you've cleared the significant hurdles and crossed the finish line, validating other prospects/opportunities will become much easier with a substantial validation under your belt.

    Cheers

    M.oz
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $51.40M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $8.723K 459.1K

Buyers (Bids)

No. Vol. Price($)
2 839554 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 976767 4
View Market Depth
Last trade - 09.59am 01/08/2025 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.